by Combat Cancer | Apr 18, 2025 | News
For many patients, the dread of colonoscopy is more than just physical discomfort – it’s psychological. The invasiveness of the procedure, the bowel prep, the vulnerability of the experience – all combine to create a cocktail of stress and anxiety....
by Combat Cancer | Apr 12, 2025 | News
While lifestyle and environmental factors play a significant role in the development of bowel cancer, there can also be a hereditary component in a small number of cases. Understanding these underlying genetic causes is essential for early diagnosis and intervention,...
by Combat Cancer | Apr 5, 2025 | News
We are proud to announce our upcoming HIVEC®-HEAT Study, which is set to commence enrolment in May 2025. This trial represents a major milestone in the search for effective and less aggressive forms of treatment for non-muscle invasive bladder cancer (NMIBC). The...
by Combat Cancer | Mar 29, 2025 | News
Ovarian cancer is one of the most challenging and elusive cancers affecting women. According to data from Cancer Research UK (CRUK)*, the estimated lifetime risk of being diagnosed with ovarian cancer is estimated to be 1 in 56 – about 2% – for women born...
by Combat Cancer | Mar 22, 2025 | News
New Hope for Patients with BCG-Unresponsive NMIBC Combat Medical is proud to announce the commencement of the HIVEC®-HEAT phase 3 trial – the main aim being to evaluate the effectiveness of our hyperthermic intravesical chemotherapy (HIVEC®) treatment with 80mg...
Recent Comments